San Francisco, CA, United States of America

Rose Yen

USPTO Granted Patents = 49 (Patent Applications = 7)

CIPO Patents = 5 (Patent Applications = 6)

EPO Patents = 13 (Patent Applications = 17)

Average Co-Inventor Count = 7.1

ph-index = 7

Forward Citations = 153(Granted Patents)

Company Filing History:

35 out of 488

Rigel Pharmaceuticals, Incorporated

patents

10 out of 12

Theravance Respiratory Company, LLC

Merck Sharp + Dohme Corp.

patents

Years Active: 2012-2025

Loading Chart...

Areas of Expertise:

Diacylglyceride O-acyltransferase 2 Inhibitors

Benzazole Compounds

IRAK Inhibitors

Amide Compounds

2,4-diamino-pyrimidine Compounds

Pyrazole Compounds

JAK Pathway Inhibition

Kinase Inhibitors

Protein Kinase C Inhibitors

Diamide Compounds

Muscarinic Receptor Antagonists

Beta2 Adrenergic Receptor Agonists

49 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12448384 - Diacylglyceride O-acyltransferase 2 inhibitors (2025-10-21),

2. 12043620 - Benzazole compounds and methods for making and using the compounds (2024-07-23),

3. 11993594 - IRAK inhibitors and method for making and using (2024-05-28),

4. 11939317 - Amide compounds and method for making and using (2024-03-26),

5. 11787810 - Diacylglyceride O-acyltransferase 2 inhibitors (2023-10-17),

6. 11530194 - Amide compounds and method for making and using (2022-12-20),

7. 11524955 - 2,4-diamino-pyrimidine compounds and method for making and using the compounds (2022-12-13),

8. 11492349 - IRAK inhibitors and method for making and using (2022-11-08),

9. 11370808 - Pyrazole compounds and methods for making and using the compounds (2022-06-28),

10. 11299486 - Benzazole compounds and methods for making and using the compounds (2022-04-12),

11. 11174251 - Compositions and methods for inhibition of the JAK pathway (2021-11-16),

12. 11059814 - Kinase inhibitors and methods for making and using (2021-07-13),

13. 10947216 - Amide compounds and method for making and using (2021-03-16),

14. 10941140 - IRAK inhibitors and method for making and using (2021-03-09),

15. 10836744 - Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity (2020-11-17),

Title: The Innovative Journey of Rose Yen

Introduction: Rose Yen, a pioneering inventor based in San Francisco, CA, has made significant contributions to the world of technology and innovation. Her passion for creating groundbreaking solutions has led to numerous patents and collaborations that have shaped various industries.

Latest Patents: Rose Yen's latest patents focus on advancements in renewable energy technologies, including solar panel efficiency optimization and energy storage solutions. Her innovative approach to sustainability has garnered attention worldwide.

Career Highlights: With a background in engineering and a keen eye for identifying gaps in the market, Rose Yen has successfully brought several inventions from concept to commercialization. Her career highlights include the development of a revolutionary medical device for remote patient monitoring and a smart home system for energy management.

Collaborations: Throughout her career, Rose Yen has collaborated with leading research institutions, universities, and tech companies to bring her inventions to life. Her ability to work across disciplines and industries has resulted in groundbreaking innovations that have improved the lives of many.

Conclusion: Rose Yen's dedication to pushing the boundaries of innovation and her commitment to creating a sustainable future make her a true trailblazer in the world of inventors. Her work continues to inspire the next generation of innovators to think creatively and fearlessly pursue their ideas.

This text is generated by artificial intelligence and may not be accurate.